Add to Calendar

SCIENTIFIC PROGRAM

Saturday 16 September, 2017
Session 1
Chairpersons: Lale Tokgözoglu (Turkey, TR), Alexandros Tselepis (Greece, GR)
09:00 - 09:30 - Atherosclerosis pathogenesis & risk factors / Alexandros Tselepis (Greece, GR)
09:30 - 10:00 - How do we determine risk in 2017? / Zeki Öngen (Turkey, TR)
10:00 - 10:30 - What is new in the 2016 prevention guidelines? / Dilek Ural (Turkey, TR)
Session 2
Chairpersons: Zeki Öngen (Turkey, TR), Konstantinos Tziomalos (Greece, GR)
11:00 - 11:30 - LDL Causality for cardiovascular disease / Vasilios Kotsis (Greece, GR)
11:30 - 12:00 - New Dyslipidemia Guidelines / Lale Tokgözoğlu (Turkey, TR)
12:00 - 12:30 - How far should we lower LDL in secondary prevention? / Hakan Kültürsay (Turkey, TR)
Session 3
Chairpersons: Hakan Kültürsay (Turkey, TR), Vasilios Kotsis (Greece, GR)
13:30 - 14:00 - Importance of FH in cardiovascular disease / Meral Kayıkçıoğlu (Turkey, TR)
14:00 - 14:30 - FH treatment / Belma Pojskic (Bosnia and Herzegovina, BA)
14:30 - 15:00 - Statins, where are we? (Including statin intolerance) / Vedat Sansoy (Turkey, TR)
15:00 - 15:30 - Update on nonstatin therapies and PCSK9 inhibitors / Konstantinos Tziomalos (Greece, GR)
Session 4
Chairpersons: Lale Tokgözoğlu (Turkey, TR), Necla Özer (Turkey, TR)
16:00 - 16:30 - Case based discussions in lipidology / Nevrez Koylan (Turkey, TR)
16:30 - 17:30 - Most frequently asked questions in lipidology panel / Meral Kayıkçıoğlu (Turkey, TR)
Sunday 17 September, 2017
Session 5
Chairpersons: Vedat Sansoy (Turkey, TR), Meral Kayıkçıoğlu (Turkey, TR)
08:30 - 09:00 - Triglycerides, are they still important? / Alberto Zambon (Italy, IT)
09:00 - 09:30 - Imaging and Biomarkers: Are they really useful? / Necla Özer (Turkey, TR)
09:30 - 10:00 - Precision medicine, is it the future? / Dilek Ural (Turkey, TR)
10:00 - 10:30 - Closing and certificates